You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Fexofenadine Market Research Report 2021 Professional Edition

Fexofenadine is an allergic symptom in a drug against an antihistamine, such as for the treatment of hay fever and urticaria. Treatment, fexofenadine is a selective peripheral H1 receptor blocker
Market Analysis and Insights: Global Fexofenadine Market
The global Fexofenadine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Fexofenadine Scope and Segment
The global Fexofenadine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fexofenadine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Purity:98%
Purity:Above 98%
By the end users/application, this report covers the following segments
Hay Fever Treatment
Urticaria Treatment
Competitive Landscape:
The report provides a list of all the key players in the Fexofenadine market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Fexofenadine key manufacturers in this market include:
Viruj Pharma
Cemex Pharma
Smaart Pharmaceutticals
Titan Pharma
AFCL
Synkromax
Farmhispania
Gen Pharma
Admiron Life Sciences Private Limited
JRC
Archerchem
Sibram
Sumitomo Chemical
Panchsheel
CAMEO HEALTH CARE
CEPiA-Sanofi
Va Sudha Pharma Chem Limited
VPL Chemicals
Zhejiang Excel Pharmaceutical
1 Fexofenadine Market Overview
1.1 Fexofenadine Product Overview
1.2 Fexofenadine Market Segment by Type
1.2.1 Purity:98%
1.2.2 Purity:Above 98%
1.3 Global Fexofenadine Market Size by Type
1.3.1 Global Fexofenadine Market Size Overview by Type (2016-2027)
1.3.2 Global Fexofenadine Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Fexofenadine Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Fexofenadine Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Fexofenadine Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Fexofenadine Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Fexofenadine Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Fexofenadine Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Fexofenadine Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Fexofenadine Sales Breakdown by Type (2016-2021)
1.4.2 Europe Fexofenadine Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Fexofenadine Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Fexofenadine Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Fexofenadine Sales Breakdown by Type (2016-2021)

2 Global Fexofenadine Market Competition by Company
2.1 Global Top Players by Fexofenadine Sales (2016-2021)
2.2 Global Top Players by Fexofenadine Revenue (2016-2021)
2.3 Global Top Players Fexofenadine Price (2016-2021)
2.4 Global Top Manufacturers Fexofenadine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Fexofenadine Market Competitive Situation and Trends
2.5.1 Fexofenadine Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Fexofenadine Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fexofenadine as of 2020)
2.7 Date of Key Manufacturers Enter into Fexofenadine Market
2.8 Key Manufacturers Fexofenadine Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Fexofenadine Status and Outlook by Region
3.1 Global Fexofenadine Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Fexofenadine Historic Market Size by Region
3.2.1 Global Fexofenadine Sales in Volume by Region (2016-2021)
3.2.2 Global Fexofenadine Sales in Value by Region (2016-2021)
3.2.3 Global Fexofenadine Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Fexofenadine Forecasted Market Size by Region
3.3.1 Global Fexofenadine Sales in Volume by Region (2022-2027)
3.3.2 Global Fexofenadine Sales in Value by Region (2022-2027)
3.3.3 Global Fexofenadine Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Fexofenadine by Application
4.1 Fexofenadine Market Segment by Application
4.1.1 Hay Fever Treatment
4.1.2 Urticaria Treatment
4.2 Global Fexofenadine Market Size by Application
4.2.1 Global Fexofenadine Market Size Overview by Application (2016-2027)
4.2.2 Global Fexofenadine Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Fexofenadine Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Fexofenadine Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Fexofenadine Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Fexofenadine Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Fexofenadine Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Fexofenadine Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Fexofenadine Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Fexofenadine Sales Breakdown by Application (2016-2021)
4.3.2 Europe Fexofenadine Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Fexofenadine Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Fexofenadine Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Fexofenadine Sales Breakdown by Application (2016-2021)

5 North America Fexofenadine by Country
5.1 North America Fexofenadine Historic Market Size by Country
5.1.1 North America Fexofenadine Sales in Volume by Country (2016-2021)
5.1.2 North America Fexofenadine Sales in Value by Country (2016-2021)
5.2 North America Fexofenadine Forecasted Market Size by Country
5.2.1 North America Fexofenadine Sales in Volume by Country (2022-2027)
5.2.2 North America Fexofenadine Sales in Value by Country (2022-2027)

6 Europe Fexofenadine by Country
6.1 Europe Fexofenadine Historic Market Size by Country
6.1.1 Europe Fexofenadine Sales in Volume by Country (2016-2021)
6.1.2 Europe Fexofenadine Sales in Value by Country (2016-2021)
6.2 Europe Fexofenadine Forecasted Market Size by Country
6.2.1 Europe Fexofenadine Sales in Volume by Country (2022-2027)
6.2.2 Europe Fexofenadine Sales in Value by Country (2022-2027)

7 Asia-Pacific Fexofenadine by Region
7.1 Asia-Pacific Fexofenadine Historic Market Size by Region
7.1.1 Asia-Pacific Fexofenadine Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Fexofenadine Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Fexofenadine Forecasted Market Size by Region
7.2.1 Asia-Pacific Fexofenadine Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Fexofenadine Sales in Value by Region (2022-2027)

8 Latin America Fexofenadine by Country
8.1 Latin America Fexofenadine Historic Market Size by Country
8.1.1 Latin America Fexofenadine Sales in Volume by Country (2016-2021)
8.1.2 Latin America Fexofenadine Sales in Value by Country (2016-2021)
8.2 Latin America Fexofenadine Forecasted Market Size by Country
8.2.1 Latin America Fexofenadine Sales in Volume by Country (2022-2027)
8.2.2 Latin America Fexofenadine Sales in Value by Country (2022-2027)

9 Middle East and Africa Fexofenadine by Country
9.1 Middle East and Africa Fexofenadine Historic Market Size by Country
9.1.1 Middle East and Africa Fexofenadine Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Fexofenadine Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Fexofenadine Forecasted Market Size by Country
9.2.1 Middle East and Africa Fexofenadine Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Fexofenadine Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Fexofenadine Business
10.1 Viruj Pharma
10.1.1 Viruj Pharma Corporation Information
10.1.2 Viruj Pharma Introduction and Business Overview
10.1.3 Viruj Pharma Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Viruj Pharma Fexofenadine Products Offered
10.1.5 Viruj Pharma Recent Development
10.2 Cemex Pharma
10.2.1 Cemex Pharma Corporation Information
10.2.2 Cemex Pharma Introduction and Business Overview
10.2.3 Cemex Pharma Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Viruj Pharma Fexofenadine Products Offered
10.2.5 Cemex Pharma Recent Development
10.3 Smaart Pharmaceutticals
10.3.1 Smaart Pharmaceutticals Corporation Information
10.3.2 Smaart Pharmaceutticals Introduction and Business Overview
10.3.3 Smaart Pharmaceutticals Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Smaart Pharmaceutticals Fexofenadine Products Offered
10.3.5 Smaart Pharmaceutticals Recent Development
10.4 Titan Pharma
10.4.1 Titan Pharma Corporation Information
10.4.2 Titan Pharma Introduction and Business Overview
10.4.3 Titan Pharma Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Titan Pharma Fexofenadine Products Offered
10.4.5 Titan Pharma Recent Development
10.5 AFCL
10.5.1 AFCL Corporation Information
10.5.2 AFCL Introduction and Business Overview
10.5.3 AFCL Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.5.4 AFCL Fexofenadine Products Offered
10.5.5 AFCL Recent Development
10.6 Synkromax
10.6.1 Synkromax Corporation Information
10.6.2 Synkromax Introduction and Business Overview
10.6.3 Synkromax Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Synkromax Fexofenadine Products Offered
10.6.5 Synkromax Recent Development
10.7 Farmhispania
10.7.1 Farmhispania Corporation Information
10.7.2 Farmhispania Introduction and Business Overview
10.7.3 Farmhispania Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Farmhispania Fexofenadine Products Offered
10.7.5 Farmhispania Recent Development
10.8 Gen Pharma
10.8.1 Gen Pharma Corporation Information
10.8.2 Gen Pharma Introduction and Business Overview
10.8.3 Gen Pharma Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Gen Pharma Fexofenadine Products Offered
10.8.5 Gen Pharma Recent Development
10.9 Admiron Life Sciences Private Limited
10.9.1 Admiron Life Sciences Private Limited Corporation Information
10.9.2 Admiron Life Sciences Private Limited Introduction and Business Overview
10.9.3 Admiron Life Sciences Private Limited Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Admiron Life Sciences Private Limited Fexofenadine Products Offered
10.9.5 Admiron Life Sciences Private Limited Recent Development
10.10 JRC
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Fexofenadine Product Category, Application and Specification
10.10.3 JRC Fexofenadine Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 JRC Recent Development
10.11 Archerchem
10.11.1 Archerchem Corporation Information
10.11.2 Archerchem Introduction and Business Overview
10.11.3 Archerchem Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Archerchem Fexofenadine Products Offered
10.11.5 Archerchem Recent Development
10.12 Sibram
10.12.1 Sibram Corporation Information
10.12.2 Sibram Introduction and Business Overview
10.12.3 Sibram Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Sibram Fexofenadine Products Offered
10.12.5 Sibram Recent Development
10.13 Sumitomo Chemical
10.13.1 Sumitomo Chemical Corporation Information
10.13.2 Sumitomo Chemical Introduction and Business Overview
10.13.3 Sumitomo Chemical Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Sumitomo Chemical Fexofenadine Products Offered
10.13.5 Sumitomo Chemical Recent Development
10.14 Panchsheel
10.14.1 Panchsheel Corporation Information
10.14.2 Panchsheel Introduction and Business Overview
10.14.3 Panchsheel Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Panchsheel Fexofenadine Products Offered
10.14.5 Panchsheel Recent Development
10.15 CAMEO HEALTH CARE
10.15.1 CAMEO HEALTH CARE Corporation Information
10.15.2 CAMEO HEALTH CARE Introduction and Business Overview
10.15.3 CAMEO HEALTH CARE Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.15.4 CAMEO HEALTH CARE Fexofenadine Products Offered
10.15.5 CAMEO HEALTH CARE Recent Development
10.16 CEPiA-Sanofi
10.16.1 CEPiA-Sanofi Corporation Information
10.16.2 CEPiA-Sanofi Introduction and Business Overview
10.16.3 CEPiA-Sanofi Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.16.4 CEPiA-Sanofi Fexofenadine Products Offered
10.16.5 CEPiA-Sanofi Recent Development
10.17 Va Sudha Pharma Chem Limited
10.17.1 Va Sudha Pharma Chem Limited Corporation Information
10.17.2 Va Sudha Pharma Chem Limited Introduction and Business Overview
10.17.3 Va Sudha Pharma Chem Limited Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Va Sudha Pharma Chem Limited Fexofenadine Products Offered
10.17.5 Va Sudha Pharma Chem Limited Recent Development
10.18 VPL Chemicals
10.18.1 VPL Chemicals Corporation Information
10.18.2 VPL Chemicals Introduction and Business Overview
10.18.3 VPL Chemicals Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.18.4 VPL Chemicals Fexofenadine Products Offered
10.18.5 VPL Chemicals Recent Development
10.19 Zhejiang Excel Pharmaceutical
10.19.1 Zhejiang Excel Pharmaceutical Corporation Information
10.19.2 Zhejiang Excel Pharmaceutical Introduction and Business Overview
10.19.3 Zhejiang Excel Pharmaceutical Fexofenadine Sales, Revenue and Gross Margin (2016-2021)
10.19.4 Zhejiang Excel Pharmaceutical Fexofenadine Products Offered
10.19.5 Zhejiang Excel Pharmaceutical Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Fexofenadine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Fexofenadine Industrial Chain Analysis
11.4 Fexofenadine Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Fexofenadine Distributors
12.3 Fexofenadine Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140